BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19877197)

  • 1. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel.
    Kishimoto Y; Hirano S; Kitani Y; Suehiro A; Umeda H; Tateya I; Kanemaru S; Tabata Y; Ito J
    Laryngoscope; 2010 Jan; 120(1):108-13. PubMed ID: 19877197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.
    Ohno T; Hirano S; Kanemaru S; Yamashita M; Umeda H; Suehiro A; Tamura Y; Nakamura T; Ito J; Tabata Y
    Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):762-9. PubMed ID: 17987782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor.
    Mizuta M; Hirano S; Ohno S; Kanemaru S; Nakamura T; Ito J
    Laryngoscope; 2014 Mar; 124(3):E81-6. PubMed ID: 24115162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar.
    Kobayashi T; Mizuta M; Hiwatashi N; Kishimoto Y; Nakamura T; Kanemaru SI; Hirano S
    Auris Nasus Larynx; 2017 Feb; 44(1):86-92. PubMed ID: 27126068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor therapy for vocal fold scarring in a canine model.
    Hirano S; Bless DM; Nagai H; Rousseau B; Welham NV; Montequin DW; Ford CN
    Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):777-85. PubMed ID: 15535139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β3 for the prevention of vocal fold scarring.
    Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Ishikawa S; Mizuta M; Tateya I; Nakamura T; Ito J
    Laryngoscope; 2012 Mar; 122(3):583-9. PubMed ID: 22252900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model.
    Hirano S; Bless DM; Rousseau B; Welham N; Montequin D; Chan RW; Ford CN
    Laryngoscope; 2004 Mar; 114(3):548-56. PubMed ID: 15091233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
    Hirano S; Bless D; Heisey D; Ford C
    Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin and adhesion molecules on canine scarred vocal folds.
    Hirano S; Bless DM; Rousseau B; Welham N; Scheidt T; Ford CN
    Laryngoscope; 2003 Jun; 113(6):966-72. PubMed ID: 12782806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar.
    Krishna P; Rosen CA; Branski RC; Wells A; Hebda PA
    Otolaryngol Head Neck Surg; 2006 Dec; 135(6):937-45. PubMed ID: 17141088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hepatocyte growth factor injection and reinjection on healing in the rabbit vocal fold.
    Dias Garcia RI; Tsuji DH; Imamura R; Mauad T; Ferraz da Silva LF
    J Voice; 2012 Sep; 26(5):667.e7-12. PubMed ID: 22296997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamina propria replacement therapy with cultured autologous fibroblasts for vocal fold scars.
    Chhetri DK; Head C; Revazova E; Hart S; Bhuta S; Berke GS
    Otolaryngol Head Neck Surg; 2004 Dec; 131(6):864-70. PubMed ID: 15577782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative histology and vibration of the vocal folds: implications for experimental studies in microlaryngeal surgery.
    Garrett CG; Coleman JR; Reinisch L
    Laryngoscope; 2000 May; 110(5 Pt 1):814-24. PubMed ID: 10807360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection.
    Hertegård S; Cedervall J; Svensson B; Forsberg K; Maurer FH; Vidovska D; Olivius P; Ahrlund-Richter L; Le Blanc K
    Laryngoscope; 2006 Jul; 116(7):1248-54. PubMed ID: 16826069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional analysis of vocal fold vibration in unilaterally atrophied larynges.
    Kobayashi J; Yumoto E; Hyodo M; Gyo K
    Laryngoscope; 2000 Mar; 110(3 Pt 1):440-6. PubMed ID: 10718435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute vocal fold scar with local injection of basic fibroblast growth factor: a canine study.
    Suehiro A; Hirano S; Kishimoto Y; Rousseau B; Nakamura T; Ito J
    Acta Otolaryngol; 2010 Jul; 130(7):844-50. PubMed ID: 20082571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new instrument for intraoperative assessment of individual vocal folds.
    Heaton JT; Kobler JB; Hillman RE; Zeitels SM
    Laryngoscope; 2005 Jul; 115(7):1223-9. PubMed ID: 15995511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of human recombinant hepatocyte growth factor administered to vocal folds.
    Mizuta M; Hirano S; Kishimoto Y; Hiwatashi N; Tateya I; Kanemaru S; Nakamura T; Ito J
    Laryngoscope; 2014 Sep; 124(9):2131-5. PubMed ID: 24668496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
    Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
    J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes in vocal functions of human scarred vocal folds after cordectomy.
    Kishimoto Y; Hirano S; Tateya I; Kanemaru S; Ito J
    Laryngoscope; 2010 Aug; 120(8):1597-601. PubMed ID: 20641077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.